FIELD: biotechnology.
SUBSTANCE: invention is the use of the human skin cell line 388mel melanoma expressing cancer-testicular antigens stored in the specialized collection of vertebrate cell cultures of the Russian collection of cell cultures under registration number RKKK (P) 728D, for production of biomedical cell products and testing of anticancer bio- and chemotherapy drugs.
EFFECT: invention allows to increase effectiveness of treatment and increase life expectancy in treatment of malignant tumors.
1 cl, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| APPLICATION OF CELL LINE OF 369 ADMEL HUMAN SKIN MELANOMA | 2017 |
|
RU2642265C1 |
| CELL PRODUCT FOR LOADING AND ACTIVATION OF HUMAN DENDRITE CELLS | 2019 |
|
RU2714208C1 |
| APPLICATION OF CELL LINE OF RC291C CLEAR CELL ADENOCARCINOMA | 2018 |
|
RU2673729C1 |
| HUMAN COLORECTAL CANCER CELL LINE 485 COLO CAN | 2017 |
|
RU2650757C1 |
| HUMAN BLADDER CANCER CELL LINE 198 BLCAN RLA | 2019 |
|
RU2733230C1 |
| HUMAN BLADDER CANCER CELL LINE 190 BICAN KAG | 2021 |
|
RU2779948C1 |
| HUMAN BLADDER CANCER CELL LINE 398 BLCAN KAE | 2020 |
|
RU2742245C1 |
| HUMAN SYNOVIAL SARCOMA CELL LINE 716 SS MNV | 2020 |
|
RU2740800C1 |
| HUMAN ALVEOLAR SARCOMA CELL LINE 9927 AIS SIO | 2022 |
|
RU2796356C1 |
| HUMAN MELANOMA CELLULAR LINE mel IL USED IN PREPARING ANTITUMOR VACCINE | 2005 |
|
RU2287577C1 |
